Leyiximeniyasisi

Kusuka e Wikipedia
Tlulela eka: Xikomba-ndlela, Lava
Leyiximeniyasisi
Skin ulcer due to leishmaniasis, hand of Central American adult 3MG0037 lores.jpg
Leyiximeniya ya nhlonge evokweni ra nkulukumba wa le xikarhi ka le Amerika
Classification and external resources
Pronunciation Leishmaniasis /ˌlʃməˈnəsɪs/
leishmaniosis /lʃˌmnɪˈsɪs/ or /lʃˌmænɪˈsɪs/[1]
Specialty Infectious disease
ICD-10 B55
ICD-9-CM 085
DiseasesDB 3266 29171
MedlinePlus 001386
eMedicine emerg/296
Patient UK Leyiximeniyasisi
MeSH D007896

Leyiximeniyasisi, leyi tsariwaka kambe leyiximaniyosi ivuvabyi lebyi vangiwaka hiphurotozowenii xitsongwatsongwanaxa muxaka waLeyiximaniyana ku hangalasiwa hi ku lumiwa hi tinxaka tin'wana taSendifulayi.[2] Vuvabyi byi nga hangalaka hi tindlela tinharhu: nhlonge , marhimila, kumbe Leximeniyasisi ya le marhumbyini[2] Ya xivumbeko xa nhlonge yi vonaka hi tialisa ta nhlonge, kasi ya xivumbeko xa marhimila yi vonaka hi tialisa ta nhlonge, nomu, na tinhompfu, na ya le marhumbyini yi sungula hi tialisa ta nhlonge na ku tivonakisa hi mukhuhlwana, ngati yi tsongo eka tisele ta ngati yo tshuka, na ku kula ka rivengo na xivindzi. [2][3]

Ku tlulela eka vanhu swi vangiwa hi ku tlula 20 wa tinxaka ta "Leyiximeniya".[2] Timhaka ta xungeto ti katsa, vusiwana, ku nga dyi kahle, ku tsemiwa ka mirhi, na ku rhurhela emadoropeni.[2] Tinxaka ha tinharhu hinkwato ti nga fembiwa hi ku vona xitsongwatsogwana eka mayikhirosikopi.[2] Ku tatisela, vuvabyi bya le marhumbyini byi nga voniwa hi ku endla swikambelwana swa ngati. [3]

Leyiximeniyasisi yi nga tsunguleka hi ku etlela ehansi ka tinete leti nga ni vutshunguri bya switsotswana .[2] Magoza yan'wana ya katsa ku fufuthela chefu ya switsotswana ku dlaya tisendifulayi na ku tshungula vanhu lava khomiweke hi vuvabyi ka ha ri na nkarhi ku sivela ku hangalaka ku ya emahlweni.[2] Vutshunguri lebyi lavekaka byi ya hi leswaku u byi kume kwihi vuvabyi, tinxaka ta "Leyiximeniya", na muxaka wa ntluleto.[2] Mirhi yin'wana leyi tirhisiwaka eka vuvabyi bya le marhumbyini yi katsa liposomali amphotheriyasini B, [4] Ku hlangana ka phentavheleti antimoniyalisina pharomosini , [4] na miltefosine.[5] eka vuvabyi bya nhlonge, pharomosin,,fulukunazolephenitamidini yi nga tirhiseka.[6]

Kwalomu ka 12 wa timiliyoni ta vanhu sweswi va tluletiwile [7] eka matiko yan'wana ya 98.[3] Kwalomu ka 2 wa timiliyoni wa timhangu letintshwa [3] na le xikarhi ka 20 na 50 wa magidi ya mafu ya va kona lembe na lembe.[2][8] Kwalomu ka 200 na   miliyoni wa vanhu eAsia, Afrika, Dzongeni na le xikarhi ka America, na Dzonga wa Europe ti tshama eka tindhawu laha vuvabyi byi nga kona.[3][9] Nhlangano wa Rihanyu wa Misava wu kumile ku tsemeriwa eka mirhi yin'wana ya ku tshungula vuvabyi.[3] Vuvabyi byi nga kumeka eka nhlayo ya swiharhi swin'wana, ku katsa na timbyana na makondlo[2]

Ku yelanisa[Lulamisa | edit source]

  1. http://www.collinsdictionary.com/dictionary/english/leishmaniasis
  2. 2.00 2.01 2.02 2.03 2.04 2.05 2.06 2.07 2.08 2.09 2.10 "Leishmaniasis Fact sheet N°375". World Health Organization. January 2014. Retrieved 17 February 2014. 
  3. 3.0 3.1 3.2 3.3 3.4 3.5 Barrett, MP; Croft, SL (2012). "Management of trypanosomiasis and leishmaniasis.". British medical bulletin 104: 175–96. PMC 3530408. PMID 23137768. doi:10.1093/bmb/lds031. 
  4. 4.0 4.1 Sundar, S; Chakravarty, J (Jan 2013). "Leishmaniasis: an update of current pharmacotherapy.". Expert opinion on pharmacotherapy 14 (1): 53–63. PMID 23256501. doi:10.1517/14656566.2013.755515. 
  5. Dorlo, TP; Balasegaram, M; Beijnen, JH; de Vries, PJ (Nov 2012). "Miltefosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis.". The Journal of antimicrobial chemotherapy 67 (11): 2576–97. PMID 22833634. doi:10.1093/jac/dks275. 
  6. Minodier, P; Parola, P (May 2007). "Cutaneous leishmaniasis treatment.". Travel medicine and infectious disease 5 (3): 150–8. PMID 17448941. doi:10.1016/j.tmaid.2006.09.004. 
  7. "Leishmaniasis Magnitude of the problem". World Health Organization. Retrieved 17 February 2014. 
  8. Lozano, R (Dec 15, 2012). "Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.". Lancet 380 (9859): 2095–128. PMID 23245604. doi:10.1016/S0140-6736(12)61728-0. 
  9. Ejazi, SA; Ali, N (Jan 2013). "Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects.". Expert review of anti-infective therapy 11 (1): 79–98. PMID 23428104. doi:10.1586/eri.12.148.